Periodic monitoring Active

Key facts

  • In September 2024, 27 countries reported measles data to EpiPulse Cases, with 245 cases reported by 17 countries. Ten countries reported zero cases.
  • Through its epidemic intelligence activities, ECDC has identified 84 new measles cases in eight EU/EEA countries reported since the last monthly update in September and not reported to ECDC.
  • In 2024, 19 measles-related deaths have been reported in Romania (18) and Ireland (1).
  • Overall in the EU/EEA, over the last 12 months, there has been high measles activity; however, the situation varies by country. Some countries have reported large and/or ongoing outbreaks and others have reported no sustained or very low transmission.
  • Updates are available for WHO Regions.

Overview

In September 2024, 27 countries reported measles data to the EpiPulse Cases, with 245 cases reported by 17 countries. Ten countries reported zero cases.

Detailed data are available in ECDC's Surveillance Atlas of Infectious Diseases.

Complementary epidemic intelligence surveillance, with data collection conducted on 12 November 2024 from official public and media sources, detected 84 new suspected and/or confirmed measles cases reported since the monthly update in October and not reported to ECDC. New cases were reported in eight EU/EEA countries: Austria (new: 2; total: 506), Bulgaria (new: 1; total: 27), Germany (new: 57; total: 755), Hungary (new: 1, total: 30), Ireland (new: 12; total: 147), Lithuania (new: 1, total: 27), the Netherlands (new: 4; total: 167), and Poland (new: 6; total: 268). Overall, 19 measles-related deaths have been reported in the EU/EEA in 2024 (18 in Romania and one in Ireland).

Updates are available for WHO Regions.

Disclaimer: The monthly measles report published in the CDTR provides the most recent data on cases and outbreaks based on information made publicly available by the national public health authorities or the media. Sometimes this information is made available retrospectively. This report is a supplement to ECDC’s monthly measles and rubella monitoring report, based on data routinely submitted by 30 EU/EEA countries to TESSy. Data presented in the two monthly reports may differ.

Epidemiological summary for EU/EEA countries with epidemic intelligence updates since last month:

Austria reported 506 confirmed measles cases in 2024 as of 12 November 2024, an increase of two cases since 8 October 2024. Of the 500 cases with available information on hospitalisation, 107 individuals (21%) were hospitalised, including four in the intensive care unit.

Bulgaria reported 27 measles cases in 2024 and as of 12 November 2024, an increase of one case since 8 October 2024. No cases were reported for the same period of the previous year.

Germany reported 755 confirmed and suspected measles cases in 2024 (data as of 12 November 2024), an increase of 57 cases since 10 October 2024.

Hungary reported 30 measles cases as of 3 November 2024, an increase of one case since 7 October 2024.

Ireland has reported 147 confirmed measles cases as of 6 November 2024, an increase of 12 cases since 8 October 2024.

Lithuania reported 27 cases in 2024 and as of 6 November 2024.

The Netherlands reported 167 measles cases in 2024 and as of 23 October 2024, an increase of four cases since 18 September 2024.

Poland reported 268 measles cases from January to 31 October 2024, an increase of six cases since 30 September 2024.

Summary of measles cases reported by WHO regional offices (as of 7 November 2024)

WHO Regional Office for Europe (WHO/EUROPE) reported 95 204 measles cases in 2024. The five non-EU/EEA countries reporting the most measles cases were: Kazakhstan (27 760), Azerbaijan (16 675), the Russian Federation (14 751), Kyrgyzstan (12 587), and the United Kingdom (2 398).

 

The numbers provided to WHO for EU/EEA countries are from TESSy data, which are updated monthly and available on the ECDC Surveillance Atlas of Infectious Diseases. Due to differences in reporting times, the numbers may not correspond to the data from epidemic intelligence screening.

 

WHO Regional Office for Africa (WHO AFRO) has reported 67 976 measles cases in 2024. The highest numbers of cases were reported from Ethiopia (26 493), Nigeria (8 243), Burkina Faso (6 457), Cote d’Ivoire (6 048) and the Democratic

Republic of the Congo (4 149).

 

WHO Regional Office for the Americas (WHO PAHO) has reported 342 measles cases in 2024. Most cases (238) were reported in the United States.

WHO Regional Office for the Eastern Mediterranean (WHO EMRO) has reported 80 607 measles cases in 2024. The highest numbers of cases were reported from Iraq (30 889), Pakistan (21 070), Yemen (17 730), Afghanistan (7 023), and Somalia (1 119).

WHO Regional Office for South-East Asia (WHO SEARO) has reported 24 541 measles cases in 2024. The highest numbers of cases were reported from India (16 934), Indonesia (4 145), Thailand (2 694), Sri Lanka (242), and Nepal (201).

WHO Regional Office for the Western Pacific (WHO WPRO) has reported 7 137 measles cases in 2024. The following five countries reported the most cases: the Philippines (3 346), Malaysia (2 647), China (665), Vietnam (347), and the Republic of Korea (47).

ECDC assessment

The overall number of measles cases in the EU/EEA has been steadily increasing since June 2023. However, for the month of September 2024, there was a decrease in the number of cases reported. Measles cases may continue to increase in the EU/EEA in the coming months. This is due to reported sub-optimal vaccination coverage for measles-containing vaccines (MCV) in a number of EU/EEA countries (<95% in many of these countries), as well as a high probability of importation from areas experiencing high circulation. In addition, the majority of recently reported cases have acquired the disease within the reported country through community/local transmission, indicating a higher probability of being exposed to the virus within the EU/EEA than in previous months.

As the number of cases is expected to rise in the near future, ECDC urges EU/EEA public health authorities to focus on the following areas:

  • Close immunity gaps, achieve and maintain high vaccination coverage for MCV (>95% with the second dose). It is vital to ensure first and second dose vaccinations are administered on time as per national schedules among infants and children. It is also important to identify and vaccinate eligible individuals (for example, non-immune adolescents and adults) in immunisation catch-up programmes (as recommended by local and national authorities).
  • Strive towards high-quality surveillance, and adequate public health capacity, especially for early detection, diagnosis, response and control of outbreaks.
  • Increase the clinical awareness of health professionals.
  • Promote vaccine acceptance and uptake by employing specific risk communication strategies and identifying drivers of sub-optimal MMR vaccine acceptance and uptake to ensure that tailored interventions are implemented in response.
  • Address barriers and engage with underserved populations. Systemic barriers that impact vaccine uptake in under-served, isolated and difficult-to-reach populations need to be monitored and addressed with targeted strategies, to reduce inequalities in vaccine uptake.


ECDC's latest advice on measles is available in the Threat Assessment Brief 'Measles on the rise in the EU/EEA: Considerations for a public health response' published in February 2024 and the conclusions of that remain valid. Additional information on the risk classification and ECDC recommendations can be found in this report.  

Actions

ECDC is monitoring the measles situation through its epidemic intelligence activities, which supplement monthly outputs with measles surveillance data from TESSy, routinely submitted by 30 EU/EEA countries. ECDC's latest advice on measles is available in the Threat Assessment Brief, 'Measles on the rise in the EU/EEA: Considerations for a public health response', published on 15 February 2024.

Latest updates for this event

View all